Prenetics Global Ltd
PRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001876431
In the last 90 days, Prenetics Global Ltd insiders filed 2 open-market purchases and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $23.3M in total; no superinvestor holds it.
Other share classesPRENW
13F holders, Q4 2022
Institutional positions in Prenetics Global Ltd as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- +2 vs. Q3 2022
- Shares held
- 6.03M
- +316.0K (+5.5%) vs. Q3 2022
- Total value
- $12.1M
- −$9.53M (−44.2%) vs. Q3 2022
- New holders
- 4
- 0 more added
- Sold out
- 2
- 2 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $23.3M |
| Q1 2026 | 34 | $38.5M |
| Q4 2025 | 33 | $27.4M |
| Q3 2025 | 16 | $17.2M |
| Q2 2025 | 11 | $9.78M |
| Q1 2025 | 9 | $4.57M |
| Q4 2024 | 9 | $6.60M |
| Q3 2024 | 8 | $4.47M |
| Q2 2024 | 7 | $7.06M |
| Q1 2024 | 9 | $60.5M |
| Q4 2023 | 6 | $7.27M |
| Q3 2023 | 15 | $7.69M |
| Q2 2023 | 20 | $14.7M |
| Q1 2023 | 14 | $5.55M |
| Q4 2022 | 12 | $12.1M |
| Q3 2022 | 10 | $21.6M |
| Q2 2022 | 11 | $23.9M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Prenetics Global Ltd; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Aspex Management (HK) Ltd | 5,192,250 | $10.4M | 0.29% | 00.0% | Unchanged |
| Dantai Capital Ltd | 448,037 | $896.1K | 0.77% | +448,037 | New |
| Dymon Asia Capital (Singapore) Pte. Ltd. | 150,687 | $301.4K | 0.71% | −66,420−30.6% | Reduced |
| Millennium Management LLC | 134,298 | $269.0K | 0.00% | −91,883−40.6% | Reduced |
| ARS Investment Partners, LLC | 35,500 | $71.0K | 0.01% | +35,500 | New |
| Fan Yu | 25,000 | $50.0K | 0.67% | 00.0% | Unchanged |
| Vident Investment Advisory, LLC | 16,218 | $32.4K | 0.00% | 00.0% | Unchanged |
| Oasis Management Co Ltd. | 11,732 | $23.5K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 10,995 | $22.0K | 0.00% | +10,995 | New |
| Bank of America Corp | 1,654 | $3.31K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,228 | $2.46K | 0.00% | +1,228 | New |
| Wolverine Asset Management LLC | 226 | $452 | 0.00% | 00.0% | Unchanged |
| Nine Masts Capital Ltd | 0 | $0 | 0.00% | −15,646−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −5,856−100.0% | Sold out |